MedPath

Comparison Between Clonidine And Dexmedetomidine As Spinal Additive In Prolongation Of Postoperative Analgesia.

Phase 3
Not yet recruiting
Conditions
Bilateral inguinal hernia, with obstruction, without gangrene,
Registration Number
CTRI/2025/06/089344
Lead Sponsor
Sudha Institute of Medical Sciences
Brief Summary

unless contraindicated, almost all the lower abdomen and lower limb surgeries are done under spinal anaesthesia using hyperbaric bupivacaine. To prolong the sensory and motor blockade duration following spinal anaesthesia various additives has been used historically, here in our study i am going to compare alpha 2 agonist clonidine and dexmedetomidine as a spinal additive in prolonging the duration of spinal analgesia, hemodynamic fluctuations and its effects on sedation.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

1.Age 20-60yrs 2.ASA grade 1 & 2 3.Willing patients.

Exclusion Criteria

1.Uncooperative patients 2.Uncontrolled DM and SHTN 3.Allergy to study drugs 4.Height <150cms 5.Contraindication to spinal anaesthesia 6.Patient refusal 7.Infection at injection site 8.Increased intracranial pressure 9.Indeterminate neurological diseases 10.Coagulopathy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Our primary objective is to evaluate the efficacy of two different drugs of same group (alpha2 adrenergic agonist) clonidine & dexmedetimidine in combination with 0.5% hyperbaric bupivacaine via intrathecal route with regard to the quality of anaesthesia namely time to attain highest sensory and motor blockade, haemodynamic changes and time to first rescue analgesia.WITHIN 24 HOURS
Secondary Outcome Measures
NameTimeMethod
sedatory effects of both drugs in the postoperative period.5months

Trial Locations

Locations (1)

sudha hospitals

🇮🇳

Erode, TAMIL NADU, India

sudha hospitals
🇮🇳Erode, TAMIL NADU, India
DrNantheta Ramu
Principal investigator
9003884668
nantheta@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.